MAFS, it is time for a reality check on solariums.
7 February 2020
Dear MAFS fans, we need to talk.
Who watched newly-wed Natasha last night rattling off her weekly ‘beauty’ routine to husband Mikey? ‘Botox, fillers, nails, hair…facials,massages, fat freezing, solarium…’
Please tell me I didn’t just hear ‘solarium’? Hearing a vibrant and educated 26 year old, with her life and world ahead of her, so casually mention her solarium use should have sent chills up your spine.
And this is why:
1. Solarium use greatly increases your risk of deadly melanoma – conclusive research on patients under 40 showed those who'd had more than 10 solarium visits in their life had up to a seven-times greater risk of developing melanoma.
2. Melanoma kills one Australian every five hours, and is the most common cancer affecting 15 to 39 year old Ausssies.
3. Commercial solariums are illegal across Australia – Melanoma Institute Australia research was integral in them being banned due to the clear link between solarium use and melanoma.
Natasha didn’t detail where she uses the solarium, but odds are there was one backyard operator sitting on their couch last night breathing a big sigh of relief that their illegal underground commercial sunbed operation wasn’t outed on national television.
Natasha’s weekly ‘beauty’ routine has today been discussed, dissected and debated online, on social media and on radio, mainly for laughs. But this is a serious issue, a potentially deadly one in fact.
The research is clear that whatever type of solarium you're using, in a home or an illegal backyard commercial operation - none of them are safe.
At a time when families across Australia are preparing to take part in Melanoma March events in memory of loved ones they have lost to melanoma, it was confronting, but most of all sad, to see a young woman choosing to put her health at risk for a tan.
It is time all Australians took melanoma seriously, including reality TV shows that air such comments so flippantly. Surely the lives of young Australians are more valuable than that.
Matthew Browne - CEO, Melanoma Institute Australia
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.
MIA has recently established a new division of our Clinical Trials Program which co-ordinates and manages investigator-led multi-centre trials.
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.
Aussies urged to leave their footprint on melanoma as efforts step up to save lives from the disease.
An evening for WA melanoma patients, carers and the wider melanoma community, where speakers will provide updates on melanoma research, treatment and support.
Olivia is using her Ninja star power to shine a spotlight on melanoma prevention - in memory of her dad.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.
Stuart has advanced melanoma which is not responding to treatment. He has shared his story on ABC's 7:30 in the hope that others can escape the same fate.
A Ninja Warrior legend and Olympic gymnast, Olivia knows first hand the devastating impact of melanoma.
All Australians are urged to join the fight against melanoma this summer.
The ground-breaking work of MIA's Co-Medical Director Prof Richard Scolyer has been recognised with NSW’s highest accolade for cancer research.
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.